about
Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999Persistence of Ebola Virus in Ocular Fluid during ConvalescenceValues for preventing influenza-related morbidity and vaccine adverse events in children.Ebola virus disease and critical illness.Development of Medical Countermeasures to Middle East Respiratory Syndrome CoronavirusAntivirals for influenza: a summary of a systematic review and meta-analysis of observational studiesLack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studiesHospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009Update on avian influenza A (H5N1) virus infection in humansThree Indonesian clusters of H5N1 virus infection in 2005Family clustering of avian influenza A (H5N1)Aerosol transmission is an important mode of influenza A virus spreadTiming of influenza A(H5N1) in poultry and humans and seasonal influenza activity worldwide, 2004-2013Modes of transmission of influenza B virus in householdsWhat is the optimal therapy for patients with H5N1 influenza?Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09Seroprevalence of antibodies to avian influenza virus A (H5N1) among residents of villages with human cases, Thailand, 2005Preliminary epidemiologic assessment of human infections with highly pathogenic avian influenza A(H5N6) virus, China.Middle East Respiratory Syndrome Coronavirus and Children.Ebola virus disease: What clinicians in the United States need to know.Care of the child with Ebola virus disease.What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention.Resource-poor settings: response, recovery, and research: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.Resource-poor settings: infrastructure and capacity building: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.Engagement and education: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.Impact of the fall 2009 influenza A(H1N1)pdm09 pandemic on US hospitals.Children with special health care needs and preparedness: experiences from seasonal influenza and the 2009 H1N1 influenza pandemic.Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008.National surveillance for influenza and influenza-like illness in Vietnam, 2006-2010.Outbreak of variant influenza A(H3N2) virus in the United States.The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012.Neuraminidase inhibitors for critically ill children with influenza.Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1.WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.Influenza-associated intensive-care unit admissions and deaths - California, September 29, 2013-January 18, 2014.Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic.Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studiesGlobal epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses.
P50
Q24646810-D4300CCE-85D6-41AB-A53F-9E851A560DFCQ24656568-1F174A21-A78A-41DA-8455-3D42327483C0Q24805596-E89DA558-C39F-45F4-A07E-1AA192A7C610Q26250274-11005E1C-C8B5-4771-8C81-EDD93A36839DQ26700054-3EDF4E47-01C8-4195-BE78-486A3E891B95Q26852067-BE380BDD-CAAD-4099-924C-02F64F49FA0CQ28257646-CDFD8240-916D-4FAF-8EB0-DA10015F171BQ28260818-6D982D49-1134-41A1-9A1F-26FF4FA1C792Q28260987-1391E687-2F57-4901-B97D-7B55BA9A26EAQ28264923-C4840308-B51D-40EC-BD4A-647F9407E750Q28275435-AAEAFCC1-83C1-4B9C-B488-E1786F4F5B13Q28292551-C5550C01-B42F-436E-BA70-20CAA6D0D4ABQ28384397-31A06105-2C50-4C92-B816-6D99F8911C4DQ28387150-18AEE76E-6BF1-44CD-85C8-1D9D0A97A8F5Q28395188-EC2F3D5A-B48E-4164-8CAA-DB73AD7AA39EQ28475630-91E41FEC-CA09-4D6C-9BF3-3DE35A6DA4B6Q28480880-813819CB-FCE8-479F-B4D3-842B27AF8E3CQ28754258-9C031124-2A64-43BC-915F-8AC67FE0E974Q30148733-13443151-A46B-4B91-9578-240AFA0AF2CDQ30151591-7ED2657D-9D91-46F2-B327-F75CD31B0FB1Q30203249-86D199BC-24A3-4C3E-8B74-9B89C94B7C56Q30204887-442961F9-F2F3-441A-AB9A-7155B1C674DAQ30207918-2F4DD983-4F92-430E-8740-197E9A765050Q30208930-C7B5CBD7-A935-40A5-919B-68B2298549BFQ30208934-11524DD0-DC51-4984-AC9B-B7BB5C8EB762Q30208942-A498AE6C-B483-4B3A-B3C6-6BBE63F65413Q30218773-76C94300-66C4-4E87-9DD9-ECD28B1167F0Q30223499-3736FE57-DC73-4D72-80F4-CBDFCF524726Q30224583-9C2259E2-9097-44C6-B399-61425F5109A6Q30227419-3AFAD79C-0FCA-456B-984E-703856D48C4BQ30352579-78412893-39C7-4663-AF89-3691FE6D46CAQ30353883-02764EA4-CB4D-44E2-BA70-34DE8BFD0FEAQ30355388-A99F596B-DB33-4065-8533-A872A9062F30Q30356037-9071518F-657D-4C3E-8975-86767415494AQ30358617-F3A965E3-2193-4137-917F-E954055C6AABQ30358901-8468C6E2-EA9A-40A8-9CD5-9347B6D01E60Q30359271-D17972B3-9061-4B53-B380-7B5DA1B6021FQ30360221-538BE248-362B-4FD8-B82D-FA11628C283AQ30364474-93802B58-521C-46E1-97B8-E01584125B43Q30368450-60CA7F89-7F8A-4E9B-8407-3477A65F214C
P50
name
Timothy M. Uyeki
@en
type
label
Timothy M. Uyeki
@en
prefLabel
Timothy M. Uyeki
@en